The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
iwNHL 2018 | Pathobiology and clinical management of T-cell lymphoma
From the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2018 meeting held in Nice, France, Francine Foss, MD, of Yale University School of Medicine, New Haven, CT, discusses the pathology and genetics of T-cell lymphoma with Jürgen Ruland, PhD, of Technical University of Munich, Munich, Germany. Prof. Foss and Prof. Ruland also expand on the nature of signalling pathways including TCR signalling and PD-1 expression in the disease, and how this impacts immunotherapies clinically investigated.
